img

Global Renal Denervation Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Renal Denervation Treatment Market Insights, Forecast to 2034

Renal denervation is a catheter-based minimally-invasive procedure. It is a therapy performed by radiofrequency or ultrasound ablation for uncontrolled hypertension. 
Market Analysis and InsightsGlobal Renal Denervation Treatment Market
Global Renal Denervation Treatment market is expected to reach to US$ 536 million in 2023, with a positive growth of %, compared with US$ 511 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Renal Denervation Treatment industry is evaluated to reach US$ 718.3 million in 2033. The CAGR will be 5.0% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Renal Denervation Treatment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Renal Denervation Treatment market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott
ReCor Medical
Boston Scientific
Cardiosonic
Medtronic
Kona medical
Mercator Medsystems
Terumo Corporation
Abbott Laboratories
Theragenics Corporation
Segment by Type
Radiofrequency
Ultrasound

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Renal Denervation Treatment introduction, etc. Renal Denervation Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Renal Denervation Treatment
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Denervation Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Radiofrequency
1.2.3 Ultrasound
1.3 Market by Application
1.3.1 Global Renal Denervation Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Denervation Treatment Market Perspective (2018-2033)
2.2 Global Renal Denervation Treatment Growth Trends by Region
2.2.1 Renal Denervation Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Renal Denervation Treatment Historic Market Size by Region (2018-2023)
2.2.3 Renal Denervation Treatment Forecasted Market Size by Region (2024-2033)
2.3 Renal Denervation Treatment Market Dynamics
2.3.1 Renal Denervation Treatment Industry Trends
2.3.2 Renal Denervation Treatment Market Drivers
2.3.3 Renal Denervation Treatment Market Challenges
2.3.4 Renal Denervation Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Renal Denervation Treatment by Players
3.1.1 Global Renal Denervation Treatment Revenue by Players (2018-2023)
3.1.2 Global Renal Denervation Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Renal Denervation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Renal Denervation Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Renal Denervation Treatment Market Concentration Ratio
3.4.1 Global Renal Denervation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Denervation Treatment Revenue in 2022
3.5 Global Key Players of Renal Denervation Treatment Head office and Area Served
3.6 Global Key Players of Renal Denervation Treatment, Product and Application
3.7 Global Key Players of Renal Denervation Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Denervation Treatment Breakdown Data by Type
4.1 Global Renal Denervation Treatment Historic Market Size by Type (2018-2023)
4.2 Global Renal Denervation Treatment Forecasted Market Size by Type (2024-2033)
5 Renal Denervation Treatment Breakdown Data by Application
5.1 Global Renal Denervation Treatment Historic Market Size by Application (2018-2023)
5.2 Global Renal Denervation Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Renal Denervation Treatment Market Size (2018-2033)
6.2 North America Renal Denervation Treatment Market Size by Type
6.2.1 North America Renal Denervation Treatment Market Size by Type (2018-2023)
6.2.2 North America Renal Denervation Treatment Market Size by Type (2024-2033)
6.2.3 North America Renal Denervation Treatment Market Share by Type (2018-2033)
6.3 North America Renal Denervation Treatment Market Size by Application
6.3.1 North America Renal Denervation Treatment Market Size by Application (2018-2023)
6.3.2 North America Renal Denervation Treatment Market Size by Application (2024-2033)
6.3.3 North America Renal Denervation Treatment Market Share by Application (2018-2033)
6.4 North America Renal Denervation Treatment Market Size by Country
6.4.1 North America Renal Denervation Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Renal Denervation Treatment Market Size by Country (2018-2023)
6.4.3 North America Renal Denervation Treatment Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Renal Denervation Treatment Market Size (2018-2033)
7.2 Europe Renal Denervation Treatment Market Size by Type
7.2.1 Europe Renal Denervation Treatment Market Size by Type (2018-2023)
7.2.2 Europe Renal Denervation Treatment Market Size by Type (2024-2033)
7.2.3 Europe Renal Denervation Treatment Market Share by Type (2018-2033)
7.3 Europe Renal Denervation Treatment Market Size by Application
7.3.1 Europe Renal Denervation Treatment Market Size by Application (2018-2023)
7.3.2 Europe Renal Denervation Treatment Market Size by Application (2024-2033)
7.3.3 Europe Renal Denervation Treatment Market Share by Application (2018-2033)
7.4 Europe Renal Denervation Treatment Market Size by Country
7.4.1 Europe Renal Denervation Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Renal Denervation Treatment Market Size by Country (2018-2023)
7.4.3 Europe Renal Denervation Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Renal Denervation Treatment Market Size (2018-2033)
8.2 China Renal Denervation Treatment Market Size by Type
8.2.1 China Renal Denervation Treatment Market Size by Type (2018-2023)
8.2.2 China Renal Denervation Treatment Market Size by Type (2024-2033)
8.2.3 China Renal Denervation Treatment Market Share by Type (2018-2033)
8.3 China Renal Denervation Treatment Market Size by Application
8.3.1 China Renal Denervation Treatment Market Size by Application (2018-2023)
8.3.2 China Renal Denervation Treatment Market Size by Application (2024-2033)
8.3.3 China Renal Denervation Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Renal Denervation Treatment Market Size (2018-2033)
9.2 Asia Renal Denervation Treatment Market Size by Type
9.2.1 Asia Renal Denervation Treatment Market Size by Type (2018-2023)
9.2.2 Asia Renal Denervation Treatment Market Size by Type (2024-2033)
9.2.3 Asia Renal Denervation Treatment Market Share by Type (2018-2033)
9.3 Asia Renal Denervation Treatment Market Size by Application
9.3.1 Asia Renal Denervation Treatment Market Size by Application (2018-2023)
9.3.2 Asia Renal Denervation Treatment Market Size by Application (2024-2033)
9.3.3 Asia Renal Denervation Treatment Market Share by Application (2018-2033)
9.4 Asia Renal Denervation Treatment Market Size by Region
9.4.1 Asia Renal Denervation Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Renal Denervation Treatment Market Size by Region (2018-2023)
9.4.3 Asia Renal Denervation Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Renal Denervation Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Renal Denervation Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Renal Denervation Treatment Introduction
11.1.4 Abbott Revenue in Renal Denervation Treatment Business (2018-2023)
11.1.5 Abbott Recent Developments
11.2 ReCor Medical
11.2.1 ReCor Medical Company Details
11.2.2 ReCor Medical Business Overview
11.2.3 ReCor Medical Renal Denervation Treatment Introduction
11.2.4 ReCor Medical Revenue in Renal Denervation Treatment Business (2018-2023)
11.2.5 ReCor Medical Recent Developments
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Renal Denervation Treatment Introduction
11.3.4 Boston Scientific Revenue in Renal Denervation Treatment Business (2018-2023)
11.3.5 Boston Scientific Recent Developments
11.4 Cardiosonic
11.4.1 Cardiosonic Company Details
11.4.2 Cardiosonic Business Overview
11.4.3 Cardiosonic Renal Denervation Treatment Introduction
11.4.4 Cardiosonic Revenue in Renal Denervation Treatment Business (2018-2023)
11.4.5 Cardiosonic Recent Developments
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Renal Denervation Treatment Introduction
11.5.4 Medtronic Revenue in Renal Denervation Treatment Business (2018-2023)
11.5.5 Medtronic Recent Developments
11.6 Kona medical
11.6.1 Kona medical Company Details
11.6.2 Kona medical Business Overview
11.6.3 Kona medical Renal Denervation Treatment Introduction
11.6.4 Kona medical Revenue in Renal Denervation Treatment Business (2018-2023)
11.6.5 Kona medical Recent Developments
11.7 Mercator Medsystems
11.7.1 Mercator Medsystems Company Details
11.7.2 Mercator Medsystems Business Overview
11.7.3 Mercator Medsystems Renal Denervation Treatment Introduction
11.7.4 Mercator Medsystems Revenue in Renal Denervation Treatment Business (2018-2023)
11.7.5 Mercator Medsystems Recent Developments
11.8 Terumo Corporation
11.8.1 Terumo Corporation Company Details
11.8.2 Terumo Corporation Business Overview
11.8.3 Terumo Corporation Renal Denervation Treatment Introduction
11.8.4 Terumo Corporation Revenue in Renal Denervation Treatment Business (2018-2023)
11.8.5 Terumo Corporation Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Renal Denervation Treatment Introduction
11.9.4 Abbott Laboratories Revenue in Renal Denervation Treatment Business (2018-2023)
11.9.5 Abbott Laboratories Recent Developments
11.10 Theragenics Corporation
11.10.1 Theragenics Corporation Company Details
11.10.2 Theragenics Corporation Business Overview
11.10.3 Theragenics Corporation Renal Denervation Treatment Introduction
11.10.4 Theragenics Corporation Revenue in Renal Denervation Treatment Business (2018-2023)
11.10.5 Theragenics Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Renal Denervation Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Radiofrequency
Table 3. Key Players of Ultrasound
Table 4. Global Renal Denervation Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Renal Denervation Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Renal Denervation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Renal Denervation Treatment Market Share by Region (2018-2023)
Table 8. Global Renal Denervation Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Renal Denervation Treatment Market Share by Region (2024-2033)
Table 10. Renal Denervation Treatment Market Trends
Table 11. Renal Denervation Treatment Market Drivers
Table 12. Renal Denervation Treatment Market Challenges
Table 13. Renal Denervation Treatment Market Restraints
Table 14. Global Renal Denervation Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Renal Denervation Treatment Revenue Share by Players (2018-2023)
Table 16. Global Top Renal Denervation Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation Treatment as of 2022)
Table 17. Global Renal Denervation Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Renal Denervation Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Renal Denervation Treatment, Headquarters and Area Served
Table 20. Global Key Players of Renal Denervation Treatment, Product and Application
Table 21. Global Key Players of Renal Denervation Treatment, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Renal Denervation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Renal Denervation Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Renal Denervation Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Renal Denervation Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Renal Denervation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Renal Denervation Treatment Revenue Share by Application (2018-2023)
Table 29. Global Renal Denervation Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Renal Denervation Treatment Revenue Share by Application (2024-2033)
Table 31. North America Renal Denervation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Renal Denervation Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Renal Denervation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Renal Denervation Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Renal Denervation Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Renal Denervation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Renal Denervation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Renal Denervation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Renal Denervation Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Renal Denervation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Renal Denervation Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Renal Denervation Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Renal Denervation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Renal Denervation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Renal Denervation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Renal Denervation Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Renal Denervation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Renal Denervation Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Renal Denervation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Renal Denervation Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Renal Denervation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Renal Denervation Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Renal Denervation Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Renal Denervation Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Renal Denervation Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Renal Denervation Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Renal Denervation Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Renal Denervation Treatment Product
Table 66. Abbott Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 67. Abbott Recent Developments
Table 68. ReCor Medical Company Details
Table 69. ReCor Medical Business Overview
Table 70. ReCor Medical Renal Denervation Treatment Product
Table 71. ReCor Medical Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 72. ReCor Medical Recent Developments
Table 73. Boston Scientific Company Details
Table 74. Boston Scientific Business Overview
Table 75. Boston Scientific Renal Denervation Treatment Product
Table 76. Boston Scientific Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 77. Boston Scientific Recent Developments
Table 78. Cardiosonic Company Details
Table 79. Cardiosonic Business Overview
Table 80. Cardiosonic Renal Denervation Treatment Product
Table 81. Cardiosonic Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 82. Cardiosonic Recent Developments
Table 83. Medtronic Company Details
Table 84. Medtronic Business Overview
Table 85. Medtronic Renal Denervation Treatment Product
Table 86. Medtronic Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 87. Medtronic Recent Developments
Table 88. Kona medical Company Details
Table 89. Kona medical Business Overview
Table 90. Kona medical Renal Denervation Treatment Product
Table 91. Kona medical Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 92. Kona medical Recent Developments
Table 93. Mercator Medsystems Company Details
Table 94. Mercator Medsystems Business Overview
Table 95. Mercator Medsystems Renal Denervation Treatment Product
Table 96. Mercator Medsystems Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 97. Mercator Medsystems Recent Developments
Table 98. Terumo Corporation Company Details
Table 99. Terumo Corporation Business Overview
Table 100. Terumo Corporation Renal Denervation Treatment Product
Table 101. Terumo Corporation Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 102. Terumo Corporation Recent Developments
Table 103. Abbott Laboratories Company Details
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories Renal Denervation Treatment Product
Table 106. Abbott Laboratories Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 107. Abbott Laboratories Recent Developments
Table 108. Theragenics Corporation Company Details
Table 109. Theragenics Corporation Business Overview
Table 110. Theragenics Corporation Renal Denervation Treatment Product
Table 111. Theragenics Corporation Revenue in Renal Denervation Treatment Business (2018-2023) & (US$ Million)
Table 112. Theragenics Corporation Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Denervation Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Renal Denervation Treatment Market Share by Type: 2022 VS 2033
Figure 3. Radiofrequency Features
Figure 4. Ultrasound Features
Figure 5. Global Renal Denervation Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Renal Denervation Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Renal Denervation Treatment Report Years Considered
Figure 11. Global Renal Denervation Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Renal Denervation Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Renal Denervation Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Renal Denervation Treatment Market Share by Players in 2022
Figure 15. Global Top Renal Denervation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Denervation Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Renal Denervation Treatment Revenue in 2022
Figure 17. North America Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Renal Denervation Treatment Market Share by Type (2018-2033)
Figure 19. North America Renal Denervation Treatment Market Share by Application (2018-2033)
Figure 20. North America Renal Denervation Treatment Market Share by Country (2018-2033)
Figure 21. United States Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Renal Denervation Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Renal Denervation Treatment Market Share by Type (2018-2033)
Figure 25. Europe Renal Denervation Treatment Market Share by Application (2018-2033)
Figure 26. Europe Renal Denervation Treatment Market Share by Country (2018-2033)
Figure 27. Germany Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Renal Denervation Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Renal Denervation Treatment Market Share by Type (2018-2033)
Figure 35. China Renal Denervation Treatment Market Share by Application (2018-2033)
Figure 36. Asia Renal Denervation Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Renal Denervation Treatment Market Share by Type (2018-2033)
Figure 38. Asia Renal Denervation Treatment Market Share by Application (2018-2033)
Figure 39. Asia Renal Denervation Treatment Market Share by Region (2018-2033)
Figure 40. Japan Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Renal Denervation Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Renal Denervation Treatment Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Renal Denervation Treatment Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Renal Denervation Treatment Market Share by Country (2018-2033)
Figure 50. Brazil Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Renal Denervation Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Abbott Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 57. ReCor Medical Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 58. Boston Scientific Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 59. Cardiosonic Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 60. Medtronic Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 61. Kona medical Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 62. Mercator Medsystems Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 63. Terumo Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 64. Abbott Laboratories Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 65. Theragenics Corporation Revenue Growth Rate in Renal Denervation Treatment Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries